Sapiens [SPNS] vs Procore Technologies [PCOR] Detailed Stock Comparison
Sapiens
NASDAQ
Loading...
Procore Technologies
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sapiens wins in 11 metrics, Procore Technologies wins in 7 metrics, with 0 ties. Sapiens appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sapiens | Procore Technologies | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.98 | -89.09 | Procore Technologies |
| Price-to-Book Ratio | 4.79 | 8.15 | Sapiens |
| Debt-to-Equity Ratio | 8.86 | 5.94 | Procore Technologies |
| PEG Ratio | -1.44 | -0.36 | Sapiens |
| EV/EBITDA | 24.69 | -98.28 | Procore Technologies |
| Profit Margin (TTM) | 12.45% | -11.58% | Sapiens |
| Operating Margin (TTM) | 11.86% | -9.04% | Sapiens |
| EBITDA Margin (TTM) | 11.86% | N/A | N/A |
| Return on Equity | 14.12% | -11.54% | Sapiens |
| Return on Assets (TTM) | 7.23% | -5.22% | Sapiens |
| Free Cash Flow (TTM) | $72.21M | $127.50M | Procore Technologies |
| Dividend Yield | 3.34% | N/A | N/A |
| 1-Year Return | 18.38% | 5.34% | Sapiens |
| Price-to-Sales Ratio (TTM) | 4.35 | 8.06 | Sapiens |
| Enterprise Value | $2.37B | $9.38B | Procore Technologies |
| EV/Revenue Ratio | 4.32 | 7.61 | Sapiens |
| Gross Profit Margin (TTM) | 43.71% | 79.09% | Procore Technologies |
| Revenue per Share (TTM) | $10 | $8 | Sapiens |
| Earnings per Share (Diluted) | $1.22 | $-0.97 | Sapiens |
| Beta (Stock Volatility) | 0.95 | 0.90 | Procore Technologies |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sapiens vs Procore Technologies Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sapiens | 0.00% | 0.09% | 41.05% | 53.08% | 52.81% | 63.70% |
| Procore Technologies | 0.59% | 0.03% | -11.92% | -3.91% | -21.36% | -13.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sapiens | 18.38% | 96.46% | 25.29% | 267.87% | 1,823.87% | 2,233.88% |
| Procore Technologies | 5.34% | 19.60% | -27.01% | -27.01% | -27.01% | -27.01% |
Performance & Financial Health Analysis: Sapiens vs Procore Technologies
| Metric | SPNS | PCOR |
|---|---|---|
| Market Information | ||
| Market Cap | $2.39B | $9.93B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 3,197,520 | 2,353,690 |
| 90 Day Avg. Volume | 1,213,870 | 2,041,307 |
| Last Close | $42.71 | $64.68 |
| 52 Week Range | $23.69 - $42.76 | $52.78 - $88.92 |
| % from 52W High | -0.12% | -27.26% |
| All-Time High | $110.00 (Jan 24, 2000) | $108.75 (Aug 02, 2021) |
| % from All-Time High | -61.17% | -40.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.14% |
| Quarterly Earnings Growth | -0.24% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | -0.12% |
| Operating Margin (TTM) | 0.12% | -0.09% |
| Return on Equity (TTM) | 0.14% | -0.12% |
| Debt to Equity (MRQ) | 8.86 | 5.94 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.92 | $8.11 |
| Cash per Share (MRQ) | $1.33 | $4.13 |
| Operating Cash Flow (TTM) | $82.42M | $165.19M |
| Levered Free Cash Flow (TTM) | $51.63M | $134.98M |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.34% | N/A |
| Last 12-Month Dividend | $0.95 | N/A |
Valuation & Enterprise Metrics Analysis: Sapiens vs Procore Technologies
| Metric | SPNS | PCOR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.98 | -89.09 |
| Forward P/E | 27.01 | 54.64 |
| PEG Ratio | -1.44 | -0.36 |
| Price to Sales (TTM) | 4.35 | 8.06 |
| Price to Book (MRQ) | 4.79 | 8.15 |
| Market Capitalization | ||
| Market Capitalization | $2.39B | $9.93B |
| Enterprise Value | $2.37B | $9.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.32 | 7.61 |
| Enterprise to EBITDA | 24.69 | -98.28 |
| Risk & Other Metrics | ||
| Beta | 0.95 | 0.90 |
| Book Value per Share (MRQ) | $8.92 | $8.11 |
Financial Statements Comparison: Sapiens vs Procore Technologies
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SPNS | PCOR |
|---|---|---|
| Revenue/Sales | $136.11M | $310.63M |
| Cost of Goods Sold | $75.45M | $64.93M |
| Gross Profit | $60.66M | $245.71M |
| Research & Development | $16.28M | $87.61M |
| Operating Income (EBIT) | $21.20M | $-36.25M |
| EBITDA | $26.06M | $-555,000 |
| Pre-Tax Income | $22.53M | $-27.70M |
| Income Tax | $4.49M | $5.29M |
| Net Income (Profit) | $18.03M | $-32.99M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SPNS | PCOR |
|---|---|---|
| Cash & Equivalents | $143.36M | $313.73M |
| Total Current Assets | $327.39M | $816.49M |
| Total Current Liabilities | $194.94M | $685.60M |
| Long-Term Debt | $16.06M | $64.50M |
| Total Shareholders Equity | $474.34M | $1.18B |
| Retained Earnings | N/A | $-1.28B |
| Property, Plant & Equipment | $30.98M | $96.45M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SPNS | PCOR |
|---|---|---|
| Operating Cash Flow | $25.14M | $87.25M |
| Capital Expenditures | $-366,000 | $-4.03M |
| Free Cash Flow | $23.04M | $46.66M |
| Debt Repayment | $-19.80M | $-388,000 |
| Common Stock Repurchase | N/A | $-100.03M |
Short Interest & Institutional Ownership Analysis
| Metric | SPNS | PCOR |
|---|---|---|
| Shares Short | 803,042 | 12.02M |
| Short Ratio | 4.14 | 8.70 |
| Short % of Float | 0.03% | 0.12% |
| Average Daily Volume (10 Day) | 3,197,520 | 2,353,690 |
| Average Daily Volume (90 Day) | 1,213,870 | 2,041,307 |
| Shares Outstanding | 55.89M | 149.85M |
| Float Shares | 30.63M | 136.82M |
| % Held by Insiders | 0.45% | 0.09% |
| % Held by Institutions | 0.37% | 0.95% |
Dividend Analysis & Yield Comparison: Sapiens vs Procore Technologies
| Metric | SPNS | PCOR |
|---|---|---|
| Last 12-Month Dividend | $0.95 | N/A |
| Last 12-Month Dividend Yield | 3.34% | N/A |
| 3-Year Avg Annual Dividend | $0.66 | N/A |
| 3-Year Avg Dividend Yield | 1.22% | N/A |
| 3-Year Total Dividends | $1.97 | N/A |
| Ex-Dividend Date | Apr 07, 2025 | N/A |